Form 8-K - Current report:
SEC Accession No. 0000950170-25-085425
Filing Date
2025-06-12
Accepted
2025-06-12 16:23:50
Documents
10
Period of Report
2025-06-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K cgem-20250612.htm   iXBRL 8-K 74381
  Complete submission text file 0000950170-25-085425.txt   181720

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cgem-20250612.xsd EX-101.SCH 24922
12 EXTRACTED XBRL INSTANCE DOCUMENT cgem-20250612_htm.xml XML 4711
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Therapeutics, Inc. (Filer) CIK: 0001789972 (see all company filings)

EIN.: 813879991 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39856 | Film No.: 251043054
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)